X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

86 percent of AARP members support the Medicare rebate rule that AARP opposes

By Holly Campbell  |    June 12, 2019
Eighty-six percent of AARP members support the administration’s proposed rule to reform the rebate system in Medicare Part D, according to a nationwide Morning Consult survey commissioned by the...   Read More

Survey: AARP members support sharing medicine discounts with seniors

By Robert Zirkelbach  |    June 12, 2019
Earlier this year, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) released a proposed rule to reform the rebate system in Medicare Part D. In our current...   Read More

What you should know: Government arbitration is the wrong way to change Medicare

By Juliet Johnson  |    June 10, 2019
As Washington looks to make changes to Medicare, there are right ways and wrong ways to address the challenges patients face. In recent weeks, policymakers have discussed imposing government...   Read More

By the numbers: A look at the Part B International Pricing Index Model

By Nicole Longo  |    June 6, 2019
Mounting research continues to point to how international reference pricing schemes, like the Department of Health and Human Services’ (HHS) International Pricing Index (IPI) Model, could result...   Read More

Assessing value top of mind at ISPOR 2019

By Samantha Dougherty  |    June 5, 2019
As we move toward a value-driven health care system, the focus should be on outcomes that matter most to patients, such as how medicines make patients feel, whether they can return to work or how...   Read More

New report finds 15 new oncology therapies launched last year

By Holly Campbell  |    June 5, 2019
A record 15 new oncology therapeutics launched in 2018 for 17 tumor types, according to IQVIA’s “Global Oncology Trends 2019” report. This progress includes a continued shift toward precision...   Read More

How the rebate rule would help reduce patients’ out-of-pocket costs

By Tom Wilbur  |    June 3, 2019
The Department of Health and Human Services recently proposed a rule that would encourage using discounts negotiated between biopharmaceutical manufacturers and Part D plans to reduce patients’...   Read More

Guest Post: Using the patient voice to go boldly

By Guest Contributor  |    May 30, 2019
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

What you need to know about the CBO rebate rule score

By Tom Wilbur  |    May 23, 2019
Earlier this year, the Department of Health & Human Services (HHS) Office of Inspector General (OIG) released a proposed rule that takes aim at today’s complex system of list prices and rebates in...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates